Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,408 | -31,383 | -46,011 | -38,048 | -32,354 |
| Depreciation Amortization | 177 | 170 | 109 | 44 | 3 |
| Accounts receivable | -2,887 | -1,906 | -871 | -557 | 0 |
| Accounts payable and accrued liabilities | -561 | -495 | -1,423 | 193 | 2,794 |
| Other Working Capital | 500 | -5,042 | -762 | -5,006 | 1,516 |
| Other Operating Activity | 12,309 | 11,280 | 11,900 | 7,354 | 641 |
| Operating Cash Flow | $3,130 | $-27,376 | $-37,058 | $-36,020 | $-27,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -174 | -127 | -151 | -25 |
| Investing Cash Flow | $-17 | $-174 | $-127 | $-151 | $-25 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 29,860 | N/A |
| Debt Repayment | -9,207 | -4,856 | -1,025 | 0 | N/A |
| Common Stock Issued | 22,281 | 1,777 | 55 | 59,708 | 42,482 |
| Financing Cash Flow | $13,074 | $-3,079 | $-970 | $89,568 | $42,482 |
| Beginning Cash Position | 24,248 | 54,877 | 93,032 | 39,635 | 24,578 |
| End Cash Position | 40,435 | 24,248 | 54,877 | 93,032 | 39,635 |
| Net Cash Flow | $16,187 | $-30,629 | $-38,155 | $53,397 | $15,057 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,130 | -27,376 | -37,058 | -36,020 | -27,400 |
| Capital Expenditure | -17 | -174 | -127 | -151 | -25 |
| Free Cash Flow | 3,113 | -27,550 | -37,185 | -36,171 | -27,425 |